AllianceBernstein Portfolio holdings
AllianceBernstein (AB), formed in 2000 through the merger of Alliance Capital and Bernstein, is a global asset management firm headquartered in Nashville, Tennessee, managing over $759 billion in assets as of late 2024 for institutional investors, financial advisors, and individuals. Known for its research-driven approach, AB offers a diverse range of investment strategies, including equities, fixed income, alternatives, and multi-asset solutions, with a strong emphasis on active management and ESG (environmental, social, governance) integration. The firm, which relocated its headquarters from New York City to Nashville in 2021, operates globally with significant operations in New York, London, and Asia, leveraging its Bernstein Research arm for deep market insights. With a workforce of over 4,700 and a partnership structure led by CEO Seth Bernstein, AB combines a legacy of rigorous analysis with a modern focus on sustainable investing and client outcomes.
Top Buys
| 1 |
Amazon
AMZN
|
+$502M |
| 2 |
Qualcomm
QCOM
|
+$481M |
| 3 |
Tesla
TSLA
|
+$453M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
+$317M |
| 5 |
Electronic Arts
EA
|
+$305M |
Top Sells
| 1 |
Apple
AAPL
|
+$447M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$325M |
| 3 |
Johnson & Johnson
JNJ
|
+$305M |
| 4 |
XLNX
Xilinx Inc
XLNX
|
+$299M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$290M |
Sector Composition
| 1 | Technology | 23.09% |
| 2 | Healthcare | 16.16% |
| 3 | Financials | 12.66% |
| 4 | Consumer Discretionary | 12.47% |
| 5 | Communication Services | 9.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2601
Atlanta Braves Holdings Series A
BATRA
$2.84B
| $481K | ﹤0.01% |
19,340
-1,200
| -6% | -$29.8K |
|
|
AWH
2602
DELISTED
Aspira Women's Health Inc. Common Stock
AWH
| $481K | ﹤0.01% |
4,780
+373
| +8% | +$37.5K |
|
2603
Marcus Corp
MCS
$485M
| $480K | ﹤0.01% |
35,587
-14,495
| -29% | -$196K |
|
2604
HCI Group
HCI
$2.31B
| $479K | ﹤0.01% |
9,150
-1,800
| -16% | -$94.2K |
|
2605
Black Diamond Therapeutics
BDTX
$183M
| $478K | ﹤0.01% |
14,900
+600
| +4% | +$19.2K |
|
2606
Quince Therapeutics
QNCX
$86.5M
| $478K | ﹤0.01% |
17,200
-2,200
| -11% | -$61.1K |
|
|
SYRS
2607
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $478K | ﹤0.01% |
4,410
-510
| -10% | -$55.3K |
|
|
ARA
2608
DELISTED
American Renal Associates Holdings, Inc
ARA
| $477K | ﹤0.01% |
41,700
-1,700
| -4% | -$19.4K |
|
2609
Green Brick Partners
GRBK
$3.17B
| $477K | ﹤0.01% |
20,763
-11,738
| -36% | -$270K |
|
2610
Select Water Solutions
WTTR
$930M
| $476K | ﹤0.01% |
116,072
+4,350
| +4% | +$17.8K |
|
2611
Future Fuel
FF
$171M
| $475K | ﹤0.01% |
37,423
-8,528
| -19% | -$108K |
|
2612
Midland States Bancorp
MSBI
$385M
| $472K | ﹤0.01% |
26,402
-2,516
| -9% | -$45K |
|
2613
Ardelyx
ARDX
$1.6B
| $472K | ﹤0.01% |
72,900
| – | – |
|
2614
KRONOS Worldwide
KRO
$721M
| $470K | ﹤0.01% |
31,500
-11,500
| -27% | -$172K |
|
2615
Boston Omaha
BOC
$421M
| $467K | ﹤0.01% |
16,900
-2,800
| -14% | -$77.4K |
|
2616
Comstock Resources
CRK
$4.65B
| $466K | ﹤0.01% |
106,600
+4,000
| +4% | +$17.5K |
|
2617
QCR Holdings
QCRH
$1.32B
| $465K | ﹤0.01% |
11,735
-3,232
| -22% | -$128K |
|
2618
Vitamin Cottage Natural Grocers
NGVC
$833M
| $464K | ﹤0.01% |
33,775
+11,375
| +51% | +$156K |
|
2619
Ducommun
DCO
$1.36B
| $463K | ﹤0.01% |
8,619
-4,634
| -35% | -$249K |
|
2620
Forrester Research
FORR
$188M
| $462K | ﹤0.01% |
11,037
-466
| -4% | -$19.5K |
|
|
CSTR
2621
DELISTED
CapStar Financial Holdings, Inc
CSTR
| $462K | ﹤0.01% |
31,297
-300
| -0.9% | -$4.43K |
|
|
BDSI
2622
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $462K | ﹤0.01% |
110,000
| – | – |
|
|
AGEN
2623
Agenus
AGEN
$154M
| $461K | ﹤0.01% |
7,393
-1,126
| -13% | -$70.2K |
|
2624
MeiraGTx Holdings
MGTX
$603M
| $457K | ﹤0.01% |
30,200
+1,700
| +6% | +$25.7K |
|
2625
Minerva Neurosciences
NERV
$15M
| $455K | ﹤0.01% |
24,313
-1,712
| -7% | -$32K |
|